ACT AlzChem Group

DGAP-News: AlzChem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 4th Interim report

DGAP-News: AlzChem Group AG / Key word(s): Share Buyback
AlzChem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 4th Interim report

15.03.2021 / 09:46
The issuer is solely responsible for the content of this announcement.

AlzChem Group AG

Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/1052


4th Interim report

In the period from March 8, 2021 up to and including March 12, 2021, a total of 370 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, 2021. The total number of shares acquired to date as part of this buyback amounts to 11.933. The acquisition was carried out by ODDO BHF Aktiengesellschaft, Frankfurt am Main/Germany via the stock exchange (XETRA) on behalf of AlzChem Group AG.

The total number of repurchased shares, the weighted average price and the aggregated volume per day were as follows:

Buyback date Total number of shares Weighted average price (EUR) Aggregated volume (EUR)
09.03.2021 250 25,0000 6.250,00
12.03.2021 120 24,7000 2.964,00
Σ 370 24,9027 9.214,00
 

This information as well as the detailed information on the individual daily transactions related to the buy-back program are also published on the Company's website at /en/investor-relations/stock/share-buy-back in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.

Trostberg, March 15, 2021

AlzChem Group AG




Contact:
Sabine Sieber
Head of Investor Relations & Communications

15.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1175531

 
End of News DGAP News Service

1175531  15.03.2021 

fncls.ssp?fn=show_t_gif&application_id=1175531&application_name=news&site_id=research_pool
EN
15/03/2021

Underlying

ACTAlzChem Group

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AlzChem Group

Peter Thilo Hasler
  • Peter Thilo Hasler
ACT ALZCHEM GROUP

Weiterhin mit robustem Gewinnwachstum

Nach wie vor ist die Ertragsentwicklung von Alzchem von konjunkturellen Herausforderungen geprägt, profitiert aber in ungleich stärkerem Maße von der Verschiebung des Umsatz-Mix in das hochmargige Segment Specialty Chemicals. Weil deshalb die vorgelegten Zahlen zum ersten Quartal 2025 erneut über unseren Schätzungen sowie den Consensus-Erwartungen lagen und wir davon ausgehen, dass die höhermargigen Potenziale weiterhin abgeschöpft werden können, heben wir unser aus einem dreiphasigen DCF-Entity...

05/05/25 May 5, 2025 36 EN
 PRESS RELEASE
Free
ACT ALZCHEM GROUP

EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung...

EQS-News: Alzchem Group AG / Schlagwort(e): Aktienrückkauf/Aktienrückkauf Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - Zeitweilige Unterbrechung des Aktienrückkaufprogramms 17.03.2025 / 11:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Alzchem Group AG   Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052       Trostberg, 17. März 2025   Zeitweilige Unterbrechung de...

March 17, 2025 1 DE
 PRESS RELEASE
Free
ACT ALZCHEM GROUP

EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the ...

EQS-News: Alzchem Group AG / Key word(s): Share Buyback/Share Buyback Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Temporary Interruption of Share Repurchase Prog 17.03.2025 / 11:38 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG   Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052     Trostberg, March 17, 2025   Temporary Inter...

March 17, 2025 1 EN
Peter Thilo Hasler
  • Peter Thilo Hasler
ACT ALZCHEM GROUP

Von hohem Niveau aus weiter aufwärts

Dass Alzchem auch im vierten Quartal 2024 sowohl die eigene Guidance als auch alle Consensus-Prognosen übertraf, kann aus unserer Sicht nicht als Normalität eingestuft werden. Kritisch ließe sich einwenden, dass die Luft angesichts des inzwischen erreichten Margenniveaus dünner wird, doch lässt die anhaltende Verschiebung zum höhermargigen Segment Specialty Chemicals nach unserer Auffassung einen erneuten Margenanstieg und einen damit einhergehenden überproportionalen Ergebnisanstieg auch im Ges...

03/03/25 March 3, 2025 38 EN
 PRESS RELEASE
Free
ACT ALZCHEM GROUP

EQS-News: Alzchem Group AG achieves record EBITDA of EUR 105.3 million...

EQS-News: Alzchem Group AG / Key word(s): Annual Results/Annual Report Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 28.02.2025 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 Free cash flow climbs significantly by 42.3% to EUR 74.2 million Dividend to be increased by 50% from EUR 1.20 to EUR 1.80 Further sales and EBITDA growth forecast for 2025 Trostberg, February 28, 2025 – Alzchem Group AG, a ...

February 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch